Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kara M. Carruthers"'
Publikováno v:
INNOVATIONS in Pharmacy, Vol 1, Iss 1 (2010)
Objectives: (1) To report the results of a pharmacist-directed cardiovascular risk management program; and (2) to identify obstacles faced by the pharmacists in the program implementation. Methods: The collaborators in this study included two loca
Externí odkaz:
https://doaj.org/article/076899d18e1e4ef0953111cfe42a2935
Publikováno v:
Journal of the American Pharmacists Association. 49:549-553
Objective To describe a pharmacist-managed health screening as a tool to identify patients who were at risk for cardiovascular disease (CVD). Design Descriptive nonexperimental study. Setting A community pharmacy, a health benefit consulting company,
Publikováno v:
Journal of the American Pharmacists Association. 48:515-517
Objective: To determine 10-year coronary heart disease (CHD) risk for union workers and their dependents in a pharmacist-managed health screening program. Methods: Two local unions of plumbers and electricians contracted with a community pharmacy to
Publikováno v:
INNOVATIONS in Pharmacy, Vol 1, Iss 1 (2010)
Objectives: (1) To report the results of a pharmacist-directed cardiovascular risk management program; and (2) to identify obstacles faced by the pharmacists in the program implementation. Methods: The collaborators in this study included two local u
Autor:
Kara M. Carruthers
Publikováno v:
Community Pharmacy Practice Case Studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0809b7264098afd4d97db8527c44faa6
https://doi.org/10.21019/9781582121055.ch35
https://doi.org/10.21019/9781582121055.ch35
Autor:
Randal P. McDonough, William R. Doucette, Yifei Liu, X. Pan, Kara M. Carruthers, Justin C. Nevins
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 47(4)
Objectives To describe the development, implementation, and financial aspects of a sustainable osteoporosis screening service in a community pharmacy and report osteoporosis risk factors for women screened during the 48 months in which the screening